SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Phipps A. I.)
 

Search: WFRF:(Phipps A. I.) > (2020-2024) > Folate intake and c...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00013783naa a2200913 4500
001oai:DiVA.org:umu-228475
003SwePub
008240816s2024 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2284752 URI
024a https://doi.org/10.1016/j.ajcnut.2024.07.0122 DOI
040 a (SwePub)umu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Aglago, Elom K.u Department of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, United Kingdom4 aut
2451 0a Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing
264 c 2024
264 1b Elsevier,c 2024
338 a electronic2 rdacarrier
520 a Background: Folate is involved in multiple genetic, epigenetic, and metabolic processes, and inadequate folate intake has been associated with an increased risk of cancer.Objective: We examined whether folate intake is differentially associated with colorectal cancer (CRC) risk according to somatic mutations in genes linked to CRC using targeted sequencing.Design: Participants within 2 large CRC consortia with available information on dietary folate, supplemental folic acid, and total folate intake were included. Colorectal tumor samples from cases were sequenced for the presence of nonsilent mutations in 105 genes and 6 signaling pathways (IGF2/PI3K, MMR, RTK/RAS, TGF-β, WNT, and TP53/ATM). Multinomial logistic regression models were analyzed comparing mutated/nonmutated CRC cases to controls to compute multivariable-adjusted odds ratios (ORs) with 95% confidence interval (CI). Heterogeneity of associations of mutated compared with nonmutated CRC cases was tested in case-only analyses using logistic regression. Analyses were performed separately in hypermutated and nonhypermutated tumors, because they exhibit different clinical behaviors.Results: We included 4339 CRC cases (702 hypermutated tumors, 16.2%) and 11,767 controls. Total folate intake was inversely associated with CRC risk (OR = 0.93; 95% CI: 0.90, 0.96). Among hypermutated tumors, 12 genes (AXIN2, B2M, BCOR, CHD1, DOCK3, FBLN2, MAP3K21, POLD1, RYR1, TET2, UTP20, and ZNF521) showed nominal statistical significance (P < 0.05) for heterogeneity by mutation status, but none remained significant after multiple testing correction. Among these genetic subtypes, the associations between folate variables and CRC were mostly inverse or toward the null, except for tumors mutated for DOCK3 (supplemental folic acid), CHD1 (total folate), and ZNF521 (dietary folate) that showed positive associations. We did not observe differential associations in analyses among nonhypermutated tumors, or according to the signaling pathways.Conclusions: Folate intake was not differentially associated with CRC risk according to mutations in the genes explored. The nominally significant differential mutation effects observed in a few genes warrants further investigation.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Medicinsk genetik0 (SwePub)301072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Medical Genetics0 (SwePub)301072 hsv//eng
653 a colorectal cancer
653 a folate
653 a folic acid
653 a molecular subtypes
653 a somatic mutations
653 a tumor
700a Qu, Conghuiu Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States4 aut
700a Harlid, Sophia,d 1978-u Umeå universitet,Onkologi4 aut0 (Swepub:umu)soha0105
700a Phipps, Amanda I.u Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States; Department of Epidemiology, University of Washington, WA, Seattle, United States4 aut
700a Steinfelder, Robert S.u Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States4 aut
700a Ogino, Shujiu Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, United States; Department of Oncologic Pathology, Dana-Farber Cancer Institute, MA, Boston, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States; Broad Institute of MIT and Harvard, MA, Cambridge, United States4 aut
700a Thomas, Claire E.u Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States4 aut
700a Hsu, Liu Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States; Department of Biostatistics, University of Washington, WA, Seattle, United States4 aut
700a Toland, Amanda E.u Department of Cancer Biology and Genetics and Internal Medicine, Comprehensive Cancer Center, The Ohio State University, OH, Columbus, United States4 aut
700a Brenner, Hermannu Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
700a Berndt, Sonja I.u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States4 aut
700a Buchanan, Daniel D.u Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, VIC, Parkville, Australia; University of Melbourne Centre for Cancer Research, The University of Melbourne, VIC, Parkville, Australia; Genomic Medicine and Family Cancer Clinic, The Royal Melbourne Hospital, VIC, Parkville, Australia4 aut
700a Campbell, Peter T.u Department of Epidemiology and Population Health, Albert Einstein College of Medicine, NY, Bronx, United States4 aut
700a Cao, Yinu Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, MO, St Louis, United States; Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, MO, St. Louis, United States; Division of Gastroenterology, Department of Medicine, Washington University School of Medicine, MO, St. Louis, United States4 aut
700a Chan, Andrew T.u Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States; Broad Institute of MIT and Harvard, MA, Cambridge, United States; Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, MA, Boston, United States; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, MA, Boston, United States; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, MA, Boston, United States; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, MA, Boston, United States4 aut
700a Drew, David A.u Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, MA, Boston, United States4 aut
700a Figueiredo, Jane C.u Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, CA, Los Angeles, United States; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, CA, Los Angeles, United States4 aut
700a French, Amy J.u Division of Laboratory Genetics, Department of Laboratory Medicine and Pathology, Mayo Clinic, MN, Rochester, United States4 aut
700a Gallinger, Stevenu Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, ON, Toronto, Canada4 aut
700a Georgeson, Peteru Colorectal Oncogenomics Group, Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, VIC, Parkville, Australia; University of Melbourne Centre for Cancer Research, The University of Melbourne, VIC, Parkville, Australia4 aut
700a Giannakis, Mariosu Broad Institute of MIT and Harvard, MA, Cambridge, United States; Department of Medical Oncology, Dana-Farber Cancer Institute, MA, Boston, United States; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, United States4 aut
700a Goode, Ellen L.u Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, MN, Rochester, United States4 aut
700a Gruber, Stephen B.u Department of Medical Oncology & Therapeutics Research and Center for Precision Medicine, City of Hope National Medical Center, CA, Duarte, United States4 aut
700a Gunter, Marc J.u Department of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, United Kingdom4 aut
700a Harrison, Tabitha A.u Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States4 aut
700a Hoffmeister, Michaelu Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany4 aut
700a Huang, Wen-Yiu Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States4 aut
700a Hullar, Meredith A.J.u Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States4 aut
700a Huyghe, Jeroen R.u Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States4 aut
700a Jenkins, Mark A.u Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, VIC, Melbourne, Australia4 aut
700a Lynch, Brigid M.u Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, VIC, Melbourne, Australia; Cancer Epidemiology Division, Cancer Council Victoria, VIC, Melbourne, Australia4 aut
700a Moreno, Victoru Unit of Biomarkers and Susceptibility (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain; Department of Clinical Sciences, Faculty of Medicine and health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona (UB), L'Hospitalet de Llobregat, Barcelona, Spain4 aut
700a Murphy, Neilu Nutrition and Metabolism Branch, International Agency for Research on Cancer, World Health Organization, Lyon, France4 aut
700a Newton, Christina C.u Ontario Institute for Cancer Research, ON, Toronto, Canada4 aut
700a Nowak, Jonathan A.u Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, MA, Boston, United States4 aut
700a Obón-Santacana, Mireiau Unit of Biomarkers and Susceptibility (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain4 aut
700a Sun, Weiu Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States4 aut
700a Ugai, Tomotakau Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States4 aut
700a Um, Caroline Y.u Department of Population Science, American Cancer Society, Atlanta, Georgia4 aut
700a Zaidi, Syed H.u Ontario Institute for Cancer Research, ON, Toronto, Canada4 aut
700a Tsilidis, Konstantinos K.u Department of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, United Kingdom; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Greece4 aut
700a van Guelpen, Bethanyu Umeå universitet,Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM),Onkologi4 aut0 (Swepub:umu)beyvan99
700a Peters, Ulrikeu Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States; Department of Epidemiology, University of Washington, WA, Seattle, United States4 aut
710a Department of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, United Kingdomb Public Health Sciences Division, Fred Hutchinson Cancer Center, WA, Seattle, United States4 org
773t American Journal of Clinical Nutritiond : Elsevierx 0002-9165x 1938-3207
856u https://doi.org/10.1016/j.ajcnut.2024.07.012y Fulltext
856u https://umu.diva-portal.org/smash/get/diva2:1889774/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-228475
8564 8u https://doi.org/10.1016/j.ajcnut.2024.07.012

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view